ArticleCentral-European journal of immunology2025
Anifrolumab in the treatment of recurrent systemic lupus erythematosus: the first post-trial case report.
Przemysław Borowy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it